author-photo

Aly-Khan A. Lalani

McMaster University
Harvard University

55

Papers

616

Citations

Citation Trend

Filter By

Papers (42) Sort By

Journal Conference Others

Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients.

2021 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.

2021 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (1)
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.

2021 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (0)
Can incomplete metastasectomy impact renal cell carcinoma outcomes? A propensity score matching analysis from a prospective multicenter collaboration

2021
Show All
- Source
- Cite
- Save
Citations (0)
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (18)
Continuing towards optimization of bladder cancer care in Canada: Summary of the 3rd BCC-CUA-CUOG bladder cancer quality of care consensus meeting

2020 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (1)
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)